Literature DB >> 34102229

The roles of PKC-δ and PKC-ε in myocardial ischemia/reperfusion injury.

Li Chen1, Dazhuo Shi2, Ming Guo3.   

Abstract

Ischemia and reperfusion (I/R) cause a reduction in arterial blood supply to tissues, followed by the restoration of perfusion and consequent reoxygenation. The reestablishment of blood flow triggers further damage to ischemic tissue through reactive oxygen species (ROS) accumulation, interference with cellular ion homeostasis, opening of mitochondrial permeability transition pores (mPTPs) and promotion of cell death (apoptosis or necrosis). PKC-δ and PKC-ε, belonging to a family of serine/threonine kinases, have been demonstrated to play important roles during I/R injury in cardiovascular diseases. However, the cardioprotective mechanisms of PKC-δ and PKC-ε in I/R injury have not been elaborated until now. This article discusses the roles of PKC-δ and PKC-ε during myocardial I/R in redox regulation (redox signaling and oxidative stress), cell death (apoptosis and necrosis), Ca2+ overload, and mitochondrial dysfunction.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardioprotection; Ischemia; PKC-δ; PKC-ε; Reperfusion

Mesh:

Substances:

Year:  2021        PMID: 34102229     DOI: 10.1016/j.phrs.2021.105716

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  8 in total

Review 1.  Cardiac Effects of Phosphodiesterase-5 Inhibitors: Efficacy and Safety.

Authors:  Sumon Roy; Robert A Kloner; Fadi N Salloum; Ion S Jovin
Journal:  Cardiovasc Drugs Ther       Date:  2021-10-15       Impact factor: 3.947

2.  Bryostatin-1 Attenuates Ischemia-Elicited Neutrophil Transmigration and Ameliorates Graft Injury after Kidney Transplantation.

Authors:  Felix Becker; Linus Kebschull; Constantin Rieger; Annika Mohr; Barbara Heitplatz; Veerle Van Marck; Uwe Hansen; Junaid Ansari; Stefan Reuter; Benjamin Strücker; Andreas Pascher; Jens G Brockmann; Trevor Castor; J Steve Alexander; Felicity N E Gavins
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

Review 3.  Role and Mechanism of PKC-δ for Cardiovascular Disease: Current Status and Perspective.

Authors:  Li-Na Miao; Deng Pan; Junhe Shi; Jian-Peng Du; Peng-Fei Chen; Jie Gao; Yanqiao Yu; Da-Zhuo Shi; Ming Guo
Journal:  Front Cardiovasc Med       Date:  2022-02-15

4.  Gluconolactone Alleviates Myocardial Ischemia/Reperfusion Injury and Arrhythmias via Activating PKCε/Extracellular Signal-Regulated Kinase Signaling.

Authors:  Xinghua Qin; Binghua Liu; Feng Gao; Yuanyuan Hu; Ziwei Chen; Jie Xu; Xing Zhang
Journal:  Front Physiol       Date:  2022-03-14       Impact factor: 4.566

5.  Putative Prevention of XML Injection Against Myocardial Ischemia Is Mediated by PKC and PLA2 Proteins.

Authors:  Ling Jin; Qianqian Yin; Yiqing Mao; Yuanxu Gao; Qing Han; Ruisi Mei; Lixiang Xue; Huanran Tan; Hui Li
Journal:  Front Cell Dev Biol       Date:  2022-01-24

6.  Effects of swimming training on myocardial protection in rats.

Authors:  Chang-Chi Lai; Chia-Yu Tang; Szu-Kai Fu; Wei-Chin Tseng; Kuo-Wei Tseng
Journal:  Biomed Rep       Date:  2022-01-31

Review 7.  Role of Oxidative Stress in Cardiac Dysfunction and Subcellular Defects Due to Ischemia-Reperfusion Injury.

Authors:  Naranjan S Dhalla; Anureet K Shah; Adriana Adameova; Monika Bartekova
Journal:  Biomedicines       Date:  2022-06-22

8.  A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury.

Authors:  Nir Qvit; Amanda J Lin; Aly Elezaby; Nicolai P Ostberg; Juliane C Campos; Julio C B Ferreira; Daria Mochly-Rosen
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.